Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Advertisement

Scientific Reports
  • View all journals
  • Search
  • My Account Login
  • Content Explore content
  • About the journal
  • Publish with us
  • Sign up for alerts
  • RSS feed
  1. nature
  2. scientific reports
  3. articles
  4. article
Hypericin-loaded small extracellular vesicles increase photodynamic therapy and remodel miRNA–mRNA axes in AGS gastric cancer cells
Download PDF
Download PDF
  • Article
  • Open access
  • Published: 06 May 2026

Hypericin-loaded small extracellular vesicles increase photodynamic therapy and remodel miRNA–mRNA axes in AGS gastric cancer cells

  • Seyedeh Faegheh Hoseini1,
  • Abbas Ali Dehpour1,
  • Roya Bishehkolaei1 &
  • …
  • Bahman Eslami Jadidi1 

Scientific Reports , Article number:  (2026) Cite this article

We are providing an unedited version of this manuscript to give early access to its findings. Before final publication, the manuscript will undergo further editing. Please note there may be errors present which affect the content, and all legal disclaimers apply.

Subjects

  • Cancer
  • Cell biology
  • Molecular biology
  • Oncology

Abstract

Gastric cancer remains a cause of cancer mortality, and there is a need for locally controllable therapies that limit systemic toxicity and overcome heterogeneous responses. Photodynamic therapy (PDT) is attractive, yet efficacy is constrained by limited intracellular availability of photosensitizers. We tested whether small extracellular vesicles (sEVs) enhance hypericin (HYP) delivery and PDT responses in AGS cells, and whether cytotoxicity aligns with transcript and epigenetic remodeling. Human sEVs were loaded with HYP by probe sonication and characterized by DLS/ELS, TEM, and CD9/CD63/CD81 flow profiling. Cells were assigned to untreated, light-only, sEV-only (+ light), free HYP (dark), free HYP + PDT, sEV–HYP (dark), or sEV–HYP + PDT; irradiation used 590 nm (3 J/cm²). sEV–HYP + PDT left-shifted dose–response and reduced IC₅₀ at 24 h (9.8 vs. 12.9 µg/mL) and 48 h (5.1 vs. 8.9 µg/mL). sEV delivery accelerated intracellular deposition: at 4 h, HYP+ cells reached 91.0% versus 68.0%, mean fluorescence intensity (MFI) increased, and HPLC confirmed higher intracellular hypericin (0.63 vs. 0.36 µg/mg protein). Enhanced deposition coincided with stronger ROS generation (3.85-fold vs. 3.10-fold; p = 0.012) and higher apoptosis (45.3% vs. 41.8%); ROS correlated with apoptosis (r = 0.992, p < 0.001). PDT also remodeled miR-21/PTEN and miR-34a/BCL2 axes and was associated with promoter methylation shifts and histone mark changes at PTEN and BCL2. Thus, sEV-mediated delivery improves intracellular HYP availability and amplifies PDT efficacy with coordinated regulatory signatures in vitro.

Acknowledgements

We sincerely thank the Vice Chancellor of Research of Islamic Azad University of Qaemshahr for supporting and facilitating this research.

Author information

Authors and Affiliations

  1. Department of Biology, QaS.C, Islamic Azad University, Qaemshahr, Iran

    Seyedeh Faegheh Hoseini, Abbas Ali Dehpour, Roya Bishehkolaei & Bahman Eslami Jadidi

Authors
  1. Seyedeh Faegheh Hoseini
    View author publications

    Search author on:PubMed Google Scholar

  2. Abbas Ali Dehpour
    View author publications

    Search author on:PubMed Google Scholar

  3. Roya Bishehkolaei
    View author publications

    Search author on:PubMed Google Scholar

  4. Bahman Eslami Jadidi
    View author publications

    Search author on:PubMed Google Scholar

Corresponding authors

Correspondence to Abbas Ali Dehpour or Roya Bishehkolaei.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary Material 1 (download PDF )

Supplementary Material 2 (download PDF )

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hoseini, S.F., Dehpour, A.A., Bishehkolaei, R. et al. Hypericin-loaded small extracellular vesicles increase photodynamic therapy and remodel miRNA–mRNA axes in AGS gastric cancer cells. Sci Rep (2026). https://doi.org/10.1038/s41598-026-48139-5

Download citation

  • Received: 19 January 2026

  • Accepted: 06 April 2026

  • Published: 06 May 2026

  • DOI: https://doi.org/10.1038/s41598-026-48139-5

Share this article

Anyone you share the following link with will be able to read this content:

Sorry, a shareable link is not currently available for this article.

Provided by the Springer Nature SharedIt content-sharing initiative

Keywords

  • Apoptotic cell death
  • Chromatin immunoprecipitation
  • Exosome-based drug delivery
  • Phototoxicity
  • Promoter DNA methylation
  • Reactive oxygen species
Download PDF

Advertisement

Explore content

  • Research articles
  • News & Comment
  • Collections
  • Subjects
  • Follow us on Facebook
  • Follow us on X
  • Sign up for alerts
  • RSS feed

About the journal

  • About Scientific Reports
  • Contact
  • Journal policies
  • Guide to referees
  • Calls for Papers
  • Editor's Choice
  • Journal highlights
  • Open Access Fees and Funding

Publish with us

  • For authors
  • Language editing services
  • Open access funding
  • Submit manuscript

Search

Advanced search

Quick links

  • Explore articles by subject
  • Find a job
  • Guide to authors
  • Editorial policies

Scientific Reports (Sci Rep)

ISSN 2045-2322 (online)

nature.com footer links

About Nature Portfolio

  • About us
  • Press releases
  • Press office
  • Contact us

Discover content

  • Journals A-Z
  • Articles by subject
  • protocols.io
  • Nature Index

Publishing policies

  • Nature portfolio policies
  • Open access

Author & Researcher services

  • Reprints & permissions
  • Research data
  • Language editing
  • Scientific editing
  • Nature Masterclasses
  • Research Solutions

Libraries & institutions

  • Librarian service & tools
  • Librarian portal
  • Open research
  • Recommend to library

Advertising & partnerships

  • Advertising
  • Partnerships & Services
  • Media kits
  • Branded content

Professional development

  • Nature Awards
  • Nature Careers
  • Nature Conferences

Regional websites

  • Nature Africa
  • Nature China
  • Nature India
  • Nature Japan
  • Nature Middle East
  • Privacy Policy
  • Use of cookies
  • Legal notice
  • Accessibility statement
  • Terms & Conditions
  • Your US state privacy rights
Springer Nature

© 2026 Springer Nature Limited

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer